• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

pipeline

Racecar speeding down a track
Biotech

Servier supercharges neuro pipeline with $450M deal

Servier plans to launch a phase 2 clinical trial for Fragile X syndrome candidate KER-0193 in Europe and the U.S. next year.
Darren Incorvaia Sep 8, 2025 2:30am
reducing people on team

AC Immune cuts workforce by 30%, trims pipeline to preserve cash

Sep 4, 2025 10:27am
Apple trees in an orchard

Treeline reaps $200M series A extension, picks first 3 programs

Sep 3, 2025 11:15am
sheet music wrong note

Prelude calls it curtains on lead SMARCA2 cancer asset

Aug 14, 2025 10:44am
Garbage truck picking up trash on suburban street

Biohaven trashes troriluzole in OCD after ph. 3 fail

Aug 12, 2025 2:06pm
Person throwing piece of paper into full waste bin

Gilead culls last MASH program, 2 cancer assets

Aug 8, 2025 11:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings